They have been reducing their positions in a considerable number of names this year, primarily to allocate at scale to the recent surge of U.S. biopharma IPOs such as Septerna.
Significant sales in the past four months include:
Revolution Medicines
Olema Pharmaceuticals
RAPT Therapeutics
Palvella Therapeutics
Agios Theraputics
Gallapagos NV
89bio Inc
4D Molecular Therapeutics Inc
Tyra Biosciences
Allakos Inc
XOMA Royalty
Elevation Holdings
Engene Holdings
GH Research
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $63.54M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 1.9¢ | $128.6K | 6.390M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 3337643 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 1075545 | 5 |
View Market Depth
| Last trade - 15.57pm 13/06/2025 (20 minute delay) ? |
| ACW (ASX) Chart |